Outputs (447)

Healthcare utilisation and costs associated with poor access to diagnosis and treatment for children and young people with tic disorders (2024)
Journal Article
Hall, C. L., Le Novere, M., Murphy, T., McNally, E., Hollis, C., & Hunter, R. (2024). Healthcare utilisation and costs associated with poor access to diagnosis and treatment for children and young people with tic disorders. BMJ Mental Health, 27(1), Article e301241. https://doi.org/10.1136/bmjment-2024-301241

BACKGROUND: There are no specific national guidelines in England to guide healthcare professionals in how to assess or treat young people with tic disorders. Access to evidence-based treatment, including behavioural therapy, is of limited availabilit... Read More about Healthcare utilisation and costs associated with poor access to diagnosis and treatment for children and young people with tic disorders.

Experiences of the COVID-19 pandemic on child and adolescent psychiatric wards: multi-methods investigation (2024)
Journal Article
Holland, J., Da-Silva-Ellimah, M., Roe, J., Morriss, R., & Sayal, K. (2024). Experiences of the COVID-19 pandemic on child and adolescent psychiatric wards: multi-methods investigation. BJPsych Open, 10(6), Article e197. https://doi.org/10.1192/bjo.2024.783

Background
Child and Adolescent Mental Health Services (CAMHS) inpatient beds are unevenly spread throughout England. Where demand outstrips bed availability, young people may be admitted at-distance or to adult psychiatric wards. The COVID-19 pande... Read More about Experiences of the COVID-19 pandemic on child and adolescent psychiatric wards: multi-methods investigation.

Dissociable effects of hyperacusis and misophonia severity imply different mechanisms of decreased sound tolerance (2024)
Journal Article
Smees, R., Simner, J., Hoare, D. J., & Ward, J. (2024). Dissociable effects of hyperacusis and misophonia severity imply different mechanisms of decreased sound tolerance. International Journal of Audiology, https://doi.org/10.1080/14992027.2024.2419558

Objective
It is thought that decreased sound tolerance can be subdivided into distinct types including misophonia (involving specific trigger sounds) and hyperacusis (broader in profile). However, there are few established methods for differentially... Read More about Dissociable effects of hyperacusis and misophonia severity imply different mechanisms of decreased sound tolerance.

Consensus‐Based Guidelines for Communicating a Misdiagnosis of Multiple Sclerosis to Reduce Psychological Distress (2024)
Journal Article
Baufeldt, A. L., Evangelou, N., Moghaddam, N., Gresswell, M., & das Nair, R. (2024). Consensus‐Based Guidelines for Communicating a Misdiagnosis of Multiple Sclerosis to Reduce Psychological Distress. Brain and Behavior, 14(10), Article e70109. https://doi.org/10.1002/brb3.70109

Background
Multiple sclerosis (MS) misdiagnosis is common, and when discovered, frequently leads to substantial disruption to patients’ lives and anxiety for clinicians. Our objective was to develop expert consensus-based guidelines about how to com... Read More about Consensus‐Based Guidelines for Communicating a Misdiagnosis of Multiple Sclerosis to Reduce Psychological Distress.

Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial (2024)
Journal Article
Werring, D. J., Dehbi, H. M., Ahmed, N., Arram, L., Best, J. G., Balogun, M., Bennett, K., Bordea, E., Caverly, E., Chau, M., Cohen, H., Cullen, M., Doré, C. J., Engelter, S. T., Fenner, R., Ford, G. A., Gill, A., Hunter, R., James, M., Jayanthi, A., …Freemantle, N. (2024). Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet, 404(10464), 1731-1741. https://doi.org/10.1016/S0140-6736%2824%2902197-4

Background: The optimal timing of anticoagulation for patients with acute ischaemic stoke with atrial fibrillation is uncertain. We investigated the efficacy and safety of early compared with delayed initiation of direct oral anticoagulants (DOACs) i... Read More about Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.

Humans: an integrative review exploring dehumanisation in advanced dementia (2024)
Journal Article
Bøgmose, J., Olivares Bøgeskov, B. M., Dening, T., & Martinsen, B. (2024). Humans: an integrative review exploring dehumanisation in advanced dementia. Nursing Ethics, https://doi.org/10.1177/09697330241277989

Background: People living with advanced dementia risk being seen as someone without personhood in contemporary societies, an understanding that has been described and challenged for decades in dementia scholarly literature. Such perception can be cha... Read More about Humans: an integrative review exploring dehumanisation in advanced dementia.

Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial (2024)
Journal Article
Slade, M., Rennick-Egglestone, S., Robinson, C., Newby, C., Elliott, R. A., Ali, Y., Yeo, C., Glover, T., Gavan, S. P., Paterson, L., Pollock, K., Priebe, S., Thornicroft, G., Keppens, J., Smuk, M., Franklin, D., Walcott, R., Harrison, J., Robotham, D., Bradstreet, S., …Ng, F. (2024). Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial. Lancet Regional Health – Europe, 47(47), Article 101101. https://doi.org/10.1016/j.lanepe.2024.101101

Background
The Narrative Experiences Online (NEON) Intervention provides self-managed web-based access to mental health recovery narratives (n = 659). We evaluated effectiveness and cost-effectiveness in improving quality of life for adults resident... Read More about Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial.

Memory for health information: Influences of age, hearing aids, and multisensory presentation (2024)
Journal Article
Stacey, J. E., Atkin, C., Roberts, K. L., Henshaw, H., Allen, H. A., & Badham, S. P. (2024). Memory for health information: Influences of age, hearing aids, and multisensory presentation. Quarterly Journal of Experimental Psychology, https://doi.org/10.1177/17470218241295722

We investigated how presenting online health information in different modalities can influence memory, as this may be particularly important for older adults who may need to make regular decisions about health and could also face additional challenge... Read More about Memory for health information: Influences of age, hearing aids, and multisensory presentation.

Implementing vocational rehabilitation for people with multiple sclerosis in the UK National Health Service: a mixed-methods feasibility study (2024)
Journal Article
De Dios Perez, B., Holmes, J., Elder, T., Lindley, R., Evangelou, N., das Nair, R., Senior, C., Booth, V., Hassard, J., Ford, H. L., Newsome, I., & Radford, K. (2024). Implementing vocational rehabilitation for people with multiple sclerosis in the UK National Health Service: a mixed-methods feasibility study. Disability and Rehabilitation, https://doi.org/10.1080/09638288.2024.2417031

Purpose: To implement a job retention vocational rehabilitation (VR) intervention (MSVR) for people with multiple sclerosis (MS) and their employers in the UK National Health Service (NHS). Methods: Multicentre, single-arm feasibility study with post... Read More about Implementing vocational rehabilitation for people with multiple sclerosis in the UK National Health Service: a mixed-methods feasibility study.

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial (2024)
Journal Article
Muir, K. W., Ford, G. A., Ford, I., Wardlaw, J. M., McConnachie, A., Greenlaw, N., Mair, G., Sprigg, N., Price, C. I., MacLeod, M. J., Dima, S., Venter, M., Zhang, L., O'Brien, E., Sanyal, R., Reid, J., Sztriha, L. K., Haider, S., Whiteley, W. N., Kennedy, J., …Douglass, C. (2024). Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial. Lancet Neurology, 23(11), 1087-1096. https://doi.org/10.1016/S1474-4422%2824%2900377-6

Background: Tenecteplase has potential benefits over alteplase, the standard agent for intravenous thrombolysis in acute ischaemic stroke, because it is administered as a single bolus and might have superior efficacy. The ATTEST-2 trial investigated... Read More about Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.